Application of HTR1B as a diagnostic marker and therapeutic target for embryonic developmental arrest
By discovering the abnormally high expression of HTR1B in embryonic developmental arrest and its impact on cell function, HTR1B is proposed as a diagnostic and therapeutic target, solving the problem of diagnosis and treatment of embryonic developmental arrest and providing new clinical application value.
Patent Information
- Application Number
- CN202410307124.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-03-18
- Publication Date
- 2024-11-26
- Estimated Expiration
- 2044-03-18
AI Technical Summary
There is a lack of effective methods for the diagnosis and treatment of embryonic developmental stagnation, and existing studies have not yet fully understood the causes and mechanisms, resulting in a lack of effective diagnostic and therapeutic targets.
It was found that HTR1B was abnormally high in embryonic developmental arrest. By establishing a human chorionic trophoblast cell model overexpressing HTR1B, its effect on cell function was evaluated, and the MAPK pathway was inhibited by the ERK inhibitor U0126, reversing mitochondrial homeostasis imbalance and over-excess Autophagy, HTR1B is proposed as a diagnostic marker and therapeutic target.
HTR1B can be used as a molecular biomarker and potential therapeutic target for embryonic development arrest. It has good clinical application value, can diagnose and assist in the diagnosis of embryonic development arrest, and provides new ideas for the development of preventive or therapeutic drugs.
Smart Images

Figure CN118308475B_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of crude drug medicine, and in particular to the application of HTR1B as a diagnostic marker and therapeutic target for embryonic development arrest. Background Art
[0002] Embryonic Arrest (EA) is a pathological pregnancy process during pregnancy. Various adverse factors after embryo implantation lead to the termination of embryonic development and subsequent embryonic death. This is a special form of spontaneous abortion, accounting for 15% of all clinical pregnancies, and has been on the rise for many years. Some known factors affecting embryonic arrest include chromosomal abnormalities, immune factors, endocrine factors, infectious factors, reproductive organ malformations, environmental factors, behavior and lifestyle habits. Embryonic arrest can occur at any stage of pregnancy, with 80% of cases occurring in the early stages. At present, there is a lack of comprehensive research and reports to provide an accurate understanding of the causes and mechanisms of potential embryonic arrest. Therefore, finding new therapeutic targets and indicators is of great significance for the diagnosis and treatment of embryonic arrest.
[0003] Placental trophoblast cells play a vital role in establishing and maintaining a healthy pregnancy. They begin to develop during blastocyst formation and differentiate into two major cell populations: cytotrophoblast (CT) and syncytiotrophoblast (ST); and extravillous trophoblast (EVT). Maintaining homeostasis within the chorionic trophoblast is essential for the health of the fetus and pregnancy. The migration and invasion of trophoblast cells at the maternal-fetal interface are key processes for successful embryo implantation. Insufficient trophoblast cell invasiveness or failure of uterine and placental vascular remodeling can lead to common obstetric complications such as miscarriage, premature birth, fetal growth restriction, fetal death, and preeclampsia. Dysfunctional trophoblast cells cannot provide enough nutrients to meet the needs of the embryo, resulting in the arrest of embryonic development. Therefore, exploring the possible pathogenic factors of placental trophoblast cells can provide some new ideas and methods for the clinical diagnosis and treatment of embryonic development arrest. Summary of the invention
[0004] Based on the technical problems existing in the background technology, the present invention proposes an application of HTR1B as a diagnostic marker and therapeutic target for embryonic development arrest. The present invention first discovered that HTR1B is abnormally highly expressed in embryonic development arrest. It was also found that overexpression of HTR1B can activate the MAPK signaling pathway of human chorionic trophoblast cells HTR8 / SVneo, causing high expression of SDHA, mitochondrial fusion-related protein OPA1, and mitochondrial fission-related protein Fis1 encoded by the nuclear gene of the trophoblast cell line HTR8 / SVneo, and then causing abnormal increase of mitochondrial autophagy-related proteins PINK1, Parkin, Beclin1, LC3II / I, etc., resulting in decreased cell survival rate and migration ability, and ultimately leading to embryonic development arrest. It was also found that after administering the ERK inhibitor U0126, the activation of the MAPK pathway caused by overexpression of HTR1B was inhibited, and the imbalance of mitochondrial homeostasis and excessive mitochondrial autophagy in human chorionic trophoblast cells HTR8 / SVneo caused by overexpression of HTR1B in vitro were also reversed. HTR1B can be used as a molecular biomarker for diagnosing embryonic developmental arrest and as a potential therapeutic target for embryonic developmental arrest, and has great clinical application value.
[0005] The present invention proposes an application of HTR1B as a biomarker in the preparation of a product for diagnosing or assisting in diagnosing embryonic development arrest.
[0006] The present invention also proposes the use of a reagent for detecting the expression level of HTR1B gene or protein in the preparation of a product for diagnosing or assisting in diagnosing embryonic development arrest.
[0007] Serotonin (5-HT) is widely distributed in the reproductive tissues of mammals. 5-HT mainly exerts its function by binding to receptors, which can be divided into 7 subfamilies: 5-HTR1, 5-HTR2, 5-HTR3, 5-HTR4, 5-HTR5, 5-HTR6 and 5-HTR7. Among these receptors, only the 5-HTR3 receptor acts as a ligand-gated ion channel, while the rest are G protein-coupled receptors. However, the role and molecular mechanism of 5-HT receptors in the process of embryonic development arrest have not been reported. The above-mentioned HTR1B is human 5-hydroxytryptamine receptor 1B.
[0008] The above-mentioned product for diagnosing or assisting in the diagnosis of embryonic developmental arrest may be a diagnostic kit or a diagnostic reagent.
[0009] Preferably, the diagnostic product or auxiliary diagnostic product is used to detect the expression level of HTR1B gene or protein in placental villus tissue.
[0010] The present invention also proposes an application of HTR1B gene or protein as a target in screening drugs for treating or preventing embryonic development arrest.
[0011] The present invention also provides a trophoblast cell model overexpressing HTR1B, wherein the cell model is a trophoblast cell HTR-8 / SVneo overexpressing HTR1B.
[0012] The trophoblast cells are human chorionic trophoblast cells HTR8 / SVneo.
[0013] The present invention also proposes a method for establishing a trophoblast cell model that overexpresses HTR1B, comprising the following steps: transfecting the HTR1B coding gene into the trophoblast cells HTR8 / SVneo, and detecting the HTR1B protein expression in the transfected trophoblast cells HTR-8 / SVneo, and screening to obtain a trophoblast cell model that overexpresses the HTR1B protein.
[0014] Preferably, the HTR1B encoding gene is transfected into trophoblast cells HTR8 / SVneo using Polyplusjet PRIME transfection reagent.
[0015] The present invention also proposes a method for detecting the mechanism of cell function damage caused by overexpression of HTR1B using the above-mentioned trophoblast cell model overexpressing HTR1B, comprising:
[0016] a. Detect the effect of overexpression of HTR1B on the expression of nuclear gene-encoded proteins in trophoblast cells HTR-8 / SVneo;
[0017] b. Detect the effect of overexpression of HTR1B on mitochondrial function of trophoblast cells HTR-8 / SVneo;
[0018] c. Detect the effect of overexpression of HTR1B on the viability and migration ability of trophoblast cells HTR-8 / SVneo;
[0019] d. Detect the effect of overexpression of HTR1B on the MAPK pathway of trophoblast cells HTR-8 / SVneo.
[0020] Mitochondria are the most abundant organelles in oocytes and early mammalian embryos, and play a vital role in embryonic development. Under certain conditions, such as external stimuli and environmental changes, the structure of mitochondria can change, leading to an imbalance in mitochondrial homeostasis and impairing their normal function. Mitochondrial abnormalities can disrupt multiple pathways, and mitochondrial fission and fusion directly affect mitochondrial metabolism, apoptosis, and autophagy. Autophagy is a self-degradation process that maintains the homeostasis of cells and biological organisms by eliminating excess or damaged subcellular proteins and / or cytoplasm. Autophagy, especially mitophagy, plays a dual role in various cell types, regulating cell survival and death.
[0021] Preferably, the nuclear gene-encoded protein includes: SDHA.
[0022] Preferably, the influence on mitochondrial function includes: influence on the expression of mitochondrial dynamics-related proteins and mitochondrial autophagy-related proteins.
[0023] Preferably, the mitochondrial power-related proteins include: OPA1 and Fis1.
[0024] Preferably, the mitochondrial autophagy-related proteins include: PINK1, Parkin, Beclin1, and LC3 II / I.
[0025] The above-mentioned nuclear gene-encoded proteins, mitochondrial dynamics-related proteins, and mitochondrial autophagy-related proteins can be detected by Western Blot method.
[0026] Beneficial effects:
[0027] The present invention first discovered that HTR1B is abnormally highly expressed in embryonic development arrest. Then, by establishing human chorionic trophoblast cells HTR8 / SVneo that overexpress HTR1B, the effects of overexpression of HTR1B on a series of functions of human chorionic trophoblast cells HTR8 / SVneo were evaluated, including the effects caused by nuclear gene-encoded proteins, mitochondrial fusion proteins, mitochondrial fission proteins, mitochondrial autophagy-related proteins, cell viability and migration ability.
[0028] The present invention finds that overexpression of HTR1B can activate the MAPK signaling pathway of human chorionic trophoblast cells HTR8 / SVneo, causing high expression of nuclear gene-encoded protein SDHA, mitochondrial fusion-related protein OPA1, and mitochondrial fission-related protein Fis1 in the trophoblast cell line HTR8 / SVneo, and then causing abnormal increase of mitochondrial autophagy-related proteins PINK1, Parkin, Beclin1, LC3 II / I, etc., resulting in decreased cell survival rate and migration ability, and ultimately leading to embryonic development stagnation.
[0029] In addition, after administering the ERK inhibitor U0126, the activation of the MAPK pathway caused by overexpression of HTR1B was inhibited in the present invention, and the imbalance of mitochondrial homeostasis and excessive mitochondrial autophagy in human chorionic trophoblast cells HTR8 / SVneo caused by overexpression of HTR1B in vitro were also reversed.
[0030] The above findings indicate that HTR1B can be used as a molecular biomarker for diagnosing embryonic developmental arrest and as a potential therapeutic target for embryonic developmental arrest, and has great clinical application value. BRIEF DESCRIPTION OF THE DRAWINGS
[0031] Figure 1The expression of HTR1B in placental villus tissue of embryonic development arrest was detected by WB and IHC. AB is the expression level and quantitative analysis results of HTR1B detected by WB, CON is the control group, EA is the experimental group, and GAPDH is the internal reference; CD is the representative picture and data analysis of HTR1B expression detected by IHC.
[0032] Figure 2 The WB method was used to detect the imbalance of mitochondrial homeostasis in the placental villus tissue of embryonic development arrest. AD was the expression of nuclear gene-encoded proteins Mitofilin, SDHA, and COXIV, and GAPDH was the internal reference; EK was the expression level of mitochondrial fusion proteins MFN1, OPA1 and mitochondrial fission proteins DRP1, Fis1, and MFF, and GAPDH and ACTIN were the internal references. CON was the control group, and EA was the experimental group.
[0033] Figure 3 The WB method was used to detect the expression of mitochondrial autophagy-related proteins in the placental villus tissue of embryonic development arrest, among which CON was the control group, EA was the experimental group, and GAPDH was the internal reference.
[0034] Figure 4 The activation of MAPK signaling pathway in placental villus tissue of embryonic development arrest was detected by WB method, where A is the protein blot detection band, BG are the quantitative analysis results of the expression levels of total ERK, phosphorylated ERK, total JNK, phosphorylated JNK, total P38, and phosphorylated P38, respectively, CON is the control group, EA is the experimental group, and GAPDH is the internal reference.
[0035] Figure 5 Figure 3 Effects of overexpression of HTR1B on the cell viability and cell migration ability of human chorionic trophoblast cells HTR8 / SVneo, where A is the result of q-PCR detection of HTR1B mRNA level in human chorionic trophoblast cells HTR-8 / SVneo after overexpression of HTR1B, with GAPDH as an internal reference; B is the cell viability results of human chorionic trophoblast cells HTR8 / Svneo overexpressing HTR1B at different time points in vitro culture; C is the result of cell migration ability detection of human chorionic trophoblast cells HTR8 / Svneo overexpressing HTR1B, CON is the control group and HTR1B is the experimental group.
[0036] Figure 6Figure 3 Effects of overexpression of HTR1B on mitochondrial homeostasis and mitophagy-related proteins in human chorionic trophoblast cells HTR-8 / SVneo. AD is the expression level of nuclear gene-encoded protein (SDHA) and mitochondrial dynamics-related proteins (OPA1, Fis1); EI is the expression level of mitophagy-related proteins (PINK1, Parkin, Beclin1, LC3 II / I); JN is the mRNA level of SDHA, COX IV, OPA1, DRP1 and Fis1. CTRL and CON were the control group, and HTR1B was the experimental group.
[0037] Figure 7 Figure 3 shows the effect of ERK inhibitor U0126 on mitochondrial homeostasis and mitophagy in HTR8 / SVneo human chorionic trophoblast cells overexpressing HTR1B. AB shows the expression levels of ERK and P-ERK proteins in non-transfected human chorionic trophoblast cells HTR8 / SVneo after treatment with different concentrations of ERK inhibitor U0126. CH shows the expression levels of nuclear gene-encoded protein SDHA, mitochondrial power-related proteins (OPA1, Fis1), and mitophagy-related proteins (Beclin1, LC3 II / I) in the inhibitor-untreated group and the inhibitor-treated group. HTR1B is the inhibitor-untreated group, and HTR1B+U0126 is the inhibitor-treated group. DETAILED DESCRIPTION
[0038] The technical solutions of the present invention are described in detail below through specific embodiments. However, it should be clearly stated that these embodiments are for illustration only and are not to be construed as limiting the scope of the present invention.
[0039] Example 1
[0040] Western Blot (WB) and immunohistochemistry (IHC) were used to detect the expression of 5-HT receptor HTR1B in placental villi of embryonic development arrest.
[0041] 1) Collecting placental chorionic villus tissue samples from patients with fetal development arrest
[0042] Chorionic villus tissues were collected from 30 patients with fetal development arrest (recorded as the experimental group) and 30 healthy pregnant women who chose to terminate their pregnancies for personal reasons (recorded as the control group). All clinical specimens were obtained from the First Affiliated Hospital of Anhui Medical University. The patients signed the informed consent form, and the Ethics Committee of the First Affiliated Hospital of Anhui Medical University approved this study.
[0043] 2) Using WB to detect the expression of HTR1B in the chorionic tissue of patients with embryonic development arrest
[0044] ① Extract protein from the villus tissue of the control group and the experimental group
[0045] Pre-cooled protein extraction reagent (containing RIPA, PMSF and phosphatase inhibitor) was added to the villus tissues of the two groups respectively, and the cells were lysed on ice for 20 min to obtain lysate; the lysate was centrifuged at 12000 rpm for 15 min in a pre-cooled centrifuge, the precipitate was discarded, the supernatant was immediately transferred to a new centrifuge tube, and Loading Buffer was added at a ratio of supernatant: Loading Buffer = 4:1, and the protein sample was obtained after being fully mixed and boiled at 100°C for 10 min, and stored at -80°C for later use;
[0046] ② Western Blot was used to detect the expression of HTR1B in the chorionic tissue of patients with embryonic development arrest
[0047] The protein samples of the two groups were separated on 12% SDS-polyacrylamide gel electrophoresis gel, then transferred to PVDF membrane and detected with HTR1B antibody. Figure 1 As shown in AB.
[0048] 3) Immunohistochemistry (IHC) detection of HTR1B expression in tissues of patients with embryonic developmental arrest
[0049] The villus tissues of the two groups were washed with 0.9% PBS solution, fixed in 4% paraformaldehyde, and embedded in paraffin blocks to cut into 4 mm thick tissue layers, and these layers were fixed on slides; then dewaxed in xylene, gradient hydration in ethanol, permeabilization and antigen retrieval, incubated with HTR1B antibody and blocked overnight at 4°C, washed three times with PBS the next day, 5 minutes each time; then incubated with secondary antibody at 37°C for 2 hours, and finally stained with DAB and hematoxylin, and images were taken with a fully automatic high-resolution panoramic imaging analysis system and the data were analyzed with Image J. The results are shown in Figure 1 CD shown.
[0050] Figure 1 The expression of HTR1B in placental villus tissue of embryonic development arrest was detected by WB and IHC. AB is the expression level and quantitative analysis results of HTR1B detected by WB, CON is the control group, EA is the experimental group, and GAPDH is the internal reference; CD is the representative picture and data analysis of HTR1B expression detected by IHC.
[0051] Figure 1 B. Figure 1 Data in D are mean ± SEM, ***p < 0.001, ****p < 0.0001.
[0052] Depend on Figure 1It can be seen that compared with the control group, the expression level of HTR1B in the placental villus tissue of patients with embryonic developmental arrest was significantly increased.
[0053] Example 2
[0054] WB method to detect mitochondrial homeostasis imbalance in placental villus tissue of patients with embryonic development arrest
[0055] ① Extract and obtain protein samples of the control group and the experimental group according to step ① of Example 1.
[0056] ②WB method was used to detect the expression of nuclear gene-encoded proteins, mitochondrial fusion-related proteins, and mitochondrial fission-related proteins in the villous tissue of embryonic development arrest.
[0057] The protein samples of the two groups were separated on a 12% SDS-polyacrylamide gel electrophoresis gel and then transferred to a nitrocellulose membrane. The samples were detected with antibodies against nuclear gene-encoded proteins (Mitofilin, SDHA, COXIV), mitochondrial fusion-related proteins (MFN1, OPA1), and mitochondrial fission-related proteins (DRP1, Fis1, MFF). The protein blot detection bands shown were quantitatively analyzed using Image J. The results are shown in Figure 2 shown.
[0058] Figure 2 The WB method was used to detect the imbalance of mitochondrial homeostasis in the placental villus tissue of embryonic development arrest. AD was the expression of nuclear gene-encoded proteins Mitofilin, SDHA, and COXIV, and GAPDH was the internal reference; EK was the expression level of mitochondrial fusion proteins MFN1, OPA1 and mitochondrial fission proteins DRP1, Fis1, and MFF, and GAPDH and ACTIN were the internal references. CON was the control group, and EA was the experimental group.
[0059] Figure 2 Statistical analysis was performed using Student's t-test and graphed using GraphPad; data are mean ± SEM, *p < 0.05, **p < 0.01, ***p < 0.001.
[0060] Depend on Figure 2It can be seen that compared with the control group, the expression levels of nuclear gene-encoded proteins (Mitofilin, SDHA, COX IV) in the placental villus tissue of the patients with embryonic development arrest were significantly changed (*p<0.05, **p<0.01); among the mitochondrial fusion-related proteins, the MFN1 protein did not change significantly, and the expression level of the OPA1 protein was dysregulated to a certain extent (*p<0.05); among the mitochondrial fission-related proteins, the DRP1 protein did not change, and the expression levels of the Fis1 and MFF proteins changed to a certain extent (*p<0.05).
[0061] Example 3
[0062] WB method was used to detect the expression of mitophagy-related proteins in the chorionic tissue of patients with embryonic arrest.
[0063] ① Extract and obtain protein samples of the control group and the experimental group according to step ① of Example 1.
[0064] ②WB method was used to detect the expression of mitochondrial autophagy-related proteins in the villous tissue of embryonic development arrest
[0065] The protein samples of the two groups were separated on a 12% SDS-polyacrylamide gel electrophoresis gel, then transferred to a nitrocellulose membrane, and detected with antibodies against mitophagy-related proteins (PINK1, Parkin, Beclin1, LC3 II / I), and the indicated western blot detection bands were quantitatively analyzed using Image J. The results are shown in Figure 3 shown.
[0066] Figure 3 The WB method was used to detect the expression of mitochondrial autophagy-related proteins in the placental villus tissue of embryonic development arrest, among which CON was the control group, EA was the experimental group, and GAPDH was the internal reference.
[0067] Figure 3 Statistical analysis was performed using Student's t-test and graphed using GraphPad; data are mean ± SEM, *p < 0.05, **p < 0.01, ***p < 0.001.
[0068] Depend on Figure 3 It can be seen that compared with the control group, the expression levels of mitochondrial autophagy-related proteins (PINK1, Parkin, Beclin1, LC3 II / I) in the placental villus tissue of the patient group with embryonic development arrest were significantly increased (*p<0.05, **p<0.01, ***p<0.001).
[0069] Example 4
[0070] The activation of MAPK signaling pathway in the chorionic tissue of patients with embryonic arrest was detected by WB.
[0071] ① Extract and obtain protein samples of the control group and the experimental group according to step ① of Example 1.
[0072] ②WB method was used to detect the expression of ERK, JNK, and P38 in the MAPK signaling pathway in the villous tissue of embryonic development arrest
[0073] The protein samples of the two groups were separated on a 12% SDS-polyacrylamide gel electrophoresis gel and then transferred to a nitrocellulose membrane and detected with antibodies to ERK, JNK, P38, phosphorylated ERK, phosphorylated JNK, and phosphorylated P38, respectively, and the indicated protein blot detection bands were quantitatively analyzed using Image J. The results are shown in Figure 4 shown.
[0074] Figure 4 The activation of MAPK signaling pathway in placental villus tissue of embryonic development arrest was detected by WB method, where A is the protein blot detection band, BG are the quantitative analysis results of the expression levels of total ERK, phosphorylated ERK, total JNK, phosphorylated JNK, total P38, and phosphorylated P38, respectively, CON is the control group, EA is the experimental group, and GAPDH is the internal reference.
[0075] Figure 4 Statistical analysis was performed using Student's t-test and graphed using GraphPad; data are mean ± SEM, *p < 0.05, **p < 0.01, ****p < 0.0001.
[0076] Depend on Figure 4 It can be seen that compared with the control group, the expression levels of total ERK (T-ERK), total JNK (T-JNK), total P38 (T-P38), phosphorylated ERK (P-ERK), phosphorylated JNK (P-JNK), and phosphorylated P38 (P-P38) in the placental villus tissue of the patient group with embryonic development arrest were increased to a certain extent (*p<0.05, **p<0.01, ****p<0.0001).
[0077] Example 5
[0078] CCK8 and scratch assays were used to detect the effects of overexpression of HTR1B on cell viability and cell migration ability of embryonic trophoblast cells HTR-8 / SVneo
[0079] 1) Construction of human chorionic trophoblast cells HTR8 / SVneo overexpressing HTR1B
[0080] ① In vitro culture of human chorionic trophoblast cells HTR-8 / SVneo:
[0081] Human chorionic trophoblast HTR-8 / SVneo cells were maintained in DMEM supplemented with 10% fetal bovine serum, 0.1 mg / L streptomycin and 100 units / ml penicillin G at 4.0 × 10 5 The cells were added to a 100 mm culture dish at a density of 10 cells / ml and cultured at 37°C in a humidified 5% CO2 incubator.
[0082] ②Cell transfection:
[0083] According to the manufacturer's recommendations, when the density of human chorionic trophoblast cells HTR-8 / SVneo in the culture dish reached 60-80%, the cells were transfected with PolyplusjetPRIME transfection reagent (purchased from Polyplus-transfection); mRNA expression analysis was performed 24 hours after transfection (the results of the mRNA level detection of HTR1B in human chorionic trophoblast cells HTR-8 / SVneo after overexpression of HTR1B are shown in Figure 5 A), protein expression analysis was performed 48 hours after transfection; and Q-PCR was used to verify the expression of HTR1B in the transfected human chorionic trophoblast cells HTR-8 / SVneo, and the cells with high HTR1B expression were selected as human chorionic trophoblast cells HTR8 / SVneo overexpressing HTR1B (referred to as trophoblast cells overexpressing HTR1B).
[0084] 2) CCK8 assay to detect the effect of overexpression of HTR1B on the cell viability of human chorionic trophoblast cells HTR-8 / SVneo
[0085] Trophoblast cells overexpressing HTR1B were used as the experimental group, and human chorionic trophoblast cells HTR8 / SVneo transfected with empty plasmid were used as the control group;
[0086] Each group of cells was seeded in a 96-well plate at a density of 5000 cells per well, and each treatment group was repeated 3 times. Incubation was carried out at 37°C and 5% CO2 for 0, 24, 48, or 72 h; at each time point, cell viability was measured using the CCK-8 cell viability assay kit according to the manufacturer's instructions. The results are shown in Figure 5 shown.
[0087] 3) Scratch assay was used to detect the effect of overexpression of HTR1B on the cell migration ability of human chorionic trophoblast cells
[0088] Trophoblast cells overexpressing HTR1B were used as the experimental group, and human chorionic trophoblast cells HTR8 / SVneo transfected with empty plasmid were used as the control group;
[0089] Take each group of cells and culture them in vitro according to step ① of Example 5. When the cell density in the culture dish reaches more than 95%, perform a cell scratch test; use 200 μl of sterilized long gun tip to vertically scratch the six-well plate, and then rinse off the separated cells with PBS; then incubate the cells with culture medium containing 1% serum at 37°C and 5% CO2; replace the culture medium at 0h, 24h, 48h, and 72h, and take photos to observe the cell migration. The results are as follows Figure 5 shown.
[0090] Figure 5 Figure 3 Effects of overexpression of HTR1B on the cell viability and cell migration ability of human chorionic trophoblast cells HTR8 / SVneo, where A is the result of q-PCR detection of HTR1B mRNA level in human chorionic trophoblast cells HTR-8 / SVneo after overexpression of HTR1B, with GAPDH as an internal reference; B is the cell viability results of human chorionic trophoblast cells HTR8 / Svneo overexpressing HTR1B at different time points in vitro culture; C is the result of cell migration ability detection of human chorionic trophoblast cells HTR8 / Svneo overexpressing HTR1B, CON is the control group and HTR1B is the experimental group.
[0091] Figure 5 Data are mean ± SEM, ****p < 0.0001.
[0092] Depend on Figure 5 It can be seen that compared with the control group, overexpression of HTR1B significantly inhibited the cell viability and cell migration ability of human chorionic trophoblast cells HTR8 / SVneo.
[0093] Example 6
[0094] Detection of the effect of overexpression of HTR1B on mitochondrial homeostasis and mitophagy-related proteins in human chorionic trophoblast cells HTR-8 / SVneo
[0095] 1) Western blot was used to detect the effect of overexpression of HTR1B on the expression level of nuclear gene-encoded protein SDHA in human chorionic trophoblast cells HTR-8 / SVneo
[0096] ① Taking trophoblast cells overexpressing HTR1B as the experimental group, and human chorionic trophoblast cells HTR8 / SVneo transfected with an empty plasmid as the control group, extracting proteins from cells in each group according to the method of step ① of Example 1 to obtain protein samples;
[0097] ②Western Blot was used to detect the effects of overexpression of HTR1B on the nuclear gene-encoded protein SDHA, mitochondrial fusion-related protein OPA1, mitochondrial fission-related protein Fis1, and mitochondrial autophagy-related proteins in human chorionic trophoblast cells HTR-8 / SVneo.
[0098] The protein samples of the two groups were separated on 12% SDS-polyacrylamide gel electrophoresis gel, and then transferred to nitrocellulose membranes. The antibodies of nuclear gene-encoded protein SDHA, mitochondrial fusion-related protein OPA1, mitochondrial fission-related protein Fis1, and mitochondrial autophagy-related proteins (PINK1, Parkin, Beclin1, LC3 II / I) were used for detection, and GAPDH was used as an internal reference. Image J was used to quantitatively analyze the protein blot detection bands shown. The results are shown in Figure 6 As shown in AI.
[0099] Figure 6 Figure 3 Effects of overexpression of HTR1B on mitochondrial homeostasis and mitophagy-related proteins in human chorionic trophoblast cells HTR-8 / SVneo. AD is the expression level of nuclear gene-encoded protein (SDHA) and mitochondrial dynamics-related proteins (OPA1, Fis1); EI is the expression level of mitophagy-related proteins (PINK1, Parkin, Beclin1, LC3 II / I); JN is the mRNA level of SDHA, COX IV, OPA1, DRP1 and Fis1. CTRL and CON were the control group, and HTR1B was the experimental group.
[0100] Figure 6 Statistical analysis was performed using t-test and graphed using GraphPad; data are mean ± SEM, *p < 0.05, **p < 0.01, ****p < 0.0001.
[0101] Depend on Figure 6 AI showed that compared with the control group, the expression level of nuclear gene-encoded protein SDHA in HTR-8 / SVneo cells overexpressing HTR1B increased to a certain extent (*p<0.05), the expression level of mitochondrial fusion-related protein OPA1 increased significantly (**p<0.01), the expression level of mitochondrial fusion-related protein Fis1 increased significantly (***p<0.001), and the mitochondrial autophagy-related proteins (PINK1, Parkin, Beclin1, LC3 II / I) increased to varying degrees.
[0102] 2) Q-PCR was used to detect the effect of HTR1B overexpression on the mRNA expression levels of mitochondrial homeostasis-related indicators (SDHA, COX IV, OPA1, DRP1 and Fis1) in human chorionic trophoblast cells HTR-8 / SVneo
[0103] ①Take trophoblast cells overexpressing HTR1B as the experimental group, and human chorionic trophoblast cells HTR8 / SVneo transfected with empty plasmid as the control group; extract RNA from cells in each group:
[0104] Take cells from each group, digest them, wash and centrifuge them, add 1 mL of Trizol solution to the cells, mix and place at room temperature for 5 minutes, then add 200 μL of chloroform, shake vigorously for 30 seconds, place at room temperature for 5 minutes, then centrifuge at 12000g for 15 minutes at 4°C, transfer the top layer of the layered liquid to an RNase-free EP tube, add an equal volume of isopropanol, mix gently and place at room temperature for 10 minutes to precipitate RNA; then centrifuge at 12000g for 10 minutes at 4°C, remove the supernatant; then add 1 mL of 75% ethanol aqueous solution, centrifuge at 10000g for 5 minutes, discard the supernatant, repeat washing twice, finally, air-dry at room temperature for 10 minutes in a clean bench, add 20 μL of DEPC water to obtain mRNA samples;
[0105] ②Use the mRNA sample as a template and use Oligo(dT) to reverse transcribe it into cDNA using reverse transcriptase:
[0106] The reverse transcription volume system was prepared as follows (EnzyArtisan, HyperScript TM III SuperMix for qPCR with gDNARemover, R202): 10 μL RNA (total amount is 1 μg RNA), 2 μL 8×gDNAremover, balance is RNase-free ddH2O, total volume is 16 μL; the above system is mixed and incubated at 42°C for 2 min, then 4 μL 5×RT SuperMix is added to the system, mixed and incubated at 37°C for 15 min, then reacted at 85°C for 5 s to obtain cDNA, which is stored at 4°C;
[0107] ③ Quantitative PCR was performed using cDNA as a template to detect the mRNA expression levels of mitochondrial homeostasis-related indicators (SDHA, COX IV, OPA1, DRP1 and Fis1) in human chorionic trophoblast cells HTR8 / SVneo after overexpression of HTR1B:
[0108] 20 μL quantitative PCR detection system (Roche, 480 GREEN I Master, 71782420): 2 μL cDNA (no more than 50 ng), 10 μL 480 GREEN I Master, 0.5 μL forward primer (final concentration of 200 nM), 0.5 μL reverse primer (final concentration of 200 nM), and the remainder was water; the sequences of the primers used for PCR amplification are shown in Table 1 below.
[0109] Table 1 Sequences of primers used for PCR amplification
[0110]
[0111]
[0112] ④ Run the amplification reaction on a fluorescent quantitative PCR instrument, using Roche 480II software reads the values and performs data analysis. Figure 6 JN.
[0113] Depend on Figure 6 JN It can be seen that compared with the control group, HTR1B overexpression had no effect on the mRNA expression levels of OPA1 and DRP1 in human chorionic trophoblast cells HTR8 / SVneo, but the mRNA expression levels of SDHA, COX IV and Fis1 increased to varying degrees (*p<0.05, ***p<0.001).
[0114] Example 7
[0115] To investigate the reversal effect of ERK inhibitor U0126 on mitochondrial homeostasis imbalance and excessive mitophagy in human chorionic trophoblast cells HTR8 / SVneo overexpressing HTR1B
[0116] 1) Treat untransfected human chorionic trophoblast cells HTR8 / SVneo with different concentrations of the ERK inhibitor U0126 to screen out the appropriate working concentration of U0126:
[0117] Untransfected human chorionic trophoblast cells HTR8 / SVneo were cultured in vitro, and treated with different concentrations of U0126 (0 μM, 1 μM, 2 μM, 5 μM, 10 μM). After 24 hours, the cells were collected, and protein samples were obtained by extracting cell proteins from each group according to step ① of Example 1;
[0118] The protein samples of each group were separated on 12% SDS-polyacrylamide gel electrophoresis gel, and then transferred to nitrocellulose membranes and detected with antibodies against ERK and phosphorylated ERK (P-ERK), respectively, with GAPDH as the internal reference. Figure 7 shown.
[0119] 2) WB method was used to detect the effect of overexpression of HTR1B on mitochondrial homeostasis-related indicators and mitochondrial autophagy-related proteins in human chorionic trophoblast cells HTR8 / SVneo after administration of 10 μM ERK inhibitor U0126:
[0120] Human chorionic trophoblast HTR8 / SVneo cells transfected with HTR1B were cultured in vitro and treated with 10 μM ERK inhibitor U0126 2 h before transfection. Protein samples were extracted from the cells 24 h after transfection and recorded as the inhibitor-treated group.
[0121] According to the above method, human chorionic trophoblast cells HTR8 / SVneo transfected for 24 hours without treatment with 10 μM ERK inhibitor U0126 were obtained, and the protein samples obtained by protein extraction were recorded as the inhibitor untreated group;
[0122] The protein samples of the two groups were separated on 12% SDS-polyacrylamide gel electrophoresis gel, and then transferred to nitrocellulose membranes. The antibodies of nuclear gene-encoded protein SDHA, mitochondrial fusion-related protein OPA1, mitochondrial fission-related protein Fis1, and mitochondrial autophagy-related proteins (Beclin1, LC3 II / I) were used for detection, and GAPDH was used as an internal reference. The indicated protein blot detection bands were quantitatively analyzed using Image J. Results Figure 7 shown.
[0123] Figure 7 Figure 3 shows the effect of ERK inhibitor U0126 on mitochondrial homeostasis and mitophagy in HTR8 / SVneo human chorionic trophoblast cells overexpressing HTR1B. AB shows the expression levels of ERK and P-ERK proteins in non-transfected human chorionic trophoblast cells HTR8 / SVneo after treatment with different concentrations of ERK inhibitor U0126. CH shows the expression levels of nuclear gene-encoded protein SDHA, mitochondrial power-related proteins (OPA1, Fis1), and mitophagy-related proteins (Beclin1, LC3 II / I) in the inhibitor-untreated group and the inhibitor-treated group. HTR1B is the inhibitor-untreated group, and HTR1B+U0126 is the inhibitor-treated group.
[0124] Figure 7Statistical analysis was performed using Student's t-test and graphed using GraphPad; data are mean ± SEM, *p < 0.05, **p < 0.01, ****p < 0.0001.
[0125] Depend on Figure 7 As can be seen from AB, compared with 0μM, the expression of phosphorylated ERK in untransfected human chorionic trophoblast cells HTR8 / SVneo was significantly reduced when the concentration of ERK inhibitor U0126 was 1μM, 2μM, 5μM, and 10μM (****p<0.0001).
[0126] Depend on Figure 7 It can be seen from CH that compared with the inhibitor-untreated group, the expressions of nuclear gene-encoded protein SDHA, mitochondrial fusion-related protein OPA1, mitochondrial fission-related protein Fis1, and mitochondrial autophagy-related proteins (Beclin1, LC3 II / I) in the transfected cells of the inhibitor-treated group decreased to varying degrees.
[0127] This indicates that the ERK inhibitor U0126 reversed the mitochondrial homeostasis imbalance and excessive mitophagy in human chorionic trophoblast cells HTR8 / SVneo overexpressing HTR1B.
[0128] The above description is only a preferred specific implementation manner of the present invention, but the protection scope of the present invention is not limited thereto. Any technician familiar with the technical field can make equivalent replacements or changes according to the technical scheme and inventive concept of the present invention within the technical scope disclosed by the present invention, which should be covered by the protection scope of the present invention.
Claims
1. Use of a reagent for detecting the expression level of HTR1B protein in placental villus tissue in the preparation of a product for diagnosing or assisting in the diagnosis of embryonic development arrest.
2. A method for detecting the mechanism of cell function damage caused by overexpression of HTR1B using a trophoblast cell model overexpressing HTR1B, It is characterized in that include: a. Detect the effect of overexpression of HTR1B on the expression of nuclear gene-encoded proteins in trophoblast cells HTR-8 / SVneo; b. Detect the effect of overexpression of HTR1B on mitochondrial function of trophoblast cells HTR-8 / SVneo; c. Detect the effect of overexpression of HTR1B on the viability and migration ability of trophoblast cells HTR-8 / SVneo; d. Detect the effect of overexpression of HTR1B on the MAPK pathway of trophoblast cells HTR-8 / SVneo; The trophoblast cell model overexpressing HTR1B is the trophoblast cell HTR-8 / SVneo overexpressing HTR1B; The nuclear gene-encoded proteins include: SDHA; The influence on mitochondrial function includes: influence on the expression of mitochondrial dynamics-related proteins and mitochondrial autophagy-related proteins; Mitochondrial dynamics-related proteins include: OPA1, Fis1; Mitochondrial autophagy-related proteins include: PINK1, Parkin, Beclin1, LC3 II / I; The related proteins of the MAPK pathway include: ERK, JNK, and P38.
